Provided by Tiger Trade Technology Pte. Ltd.

LIVZON PHARMA

29.320
+0.4201.45%
Volume:559.40K
Turnover:16.31M
Market Cap:26.04B
PE:13.09
High:29.420
Open:28.900
Low:28.840
Close:28.900
52wk High:41.850
52wk Low:23.940
Shares:888.00M
HK Float Shares:300.00M
Volume Ratio:0.60
T/O Rate:0.19%
Dividend:1.24
Dividend Rate:4.23%
EPS(LYR):2.239
ROE:16.43%
ROA:6.38%
PB:1.66
PE(LYR):13.09
PS:1.95

Loading ...

Livzon Pharmaceutical Group (01513) Releases January 2026 Monthly Return

Bulletin Express
·
Yesterday

Livzon Pharma Unit's Plaque Psoriasis Drug Granted Priority Review in China

MT Newswires Live
·
Jan 07

LIVZON PHARMA (01513): Laikangqita Monoclonal Antibody Injection Included in Priority Review and Approval Process

Stock News
·
Jan 07

LIVZON PHARMA (01513) Cancels 16.1933 Million Repurchased A-Shares on December 31

Stock News
·
Jan 05

Livzon Pharmaceutical Launches Tender Offer For Vietnam's Imexpharm, Raising Bid to 1.85 Billion Yuan

MT Newswires Live
·
Dec 31, 2025

Joincare Pharmaceutical to Divest 49% Stake in Animal Health Unit For 51.5 Million Yuan

MT Newswires Live
·
Dec 31, 2025

LIVZON PHARMA (01513): Joincare to Transfer 49% Stake in Mao Haizi to Xin You Mao Hai

Stock News
·
Dec 30, 2025

LIVZON PHARMA (01513) Appoints Xia Yu as Company's Securities Affairs Representative

Stock News
·
Dec 30, 2025

LIVZON PHARMA (01513) Submits LZM012/XKH004 for Market Approval in Plaque Psoriasis Treatment

Stock News
·
Dec 24, 2025

LIVZON PHARMA (01513): NS-041 Tablets Granted Clinical Trial Approval for Additional Indication of Depression Treatment

Stock News
·
Dec 21, 2025

LIVZON PHARMA (01513) Elects Wang Zhiyao as Independent Non-Executive Director

Stock News
·
Dec 10, 2025

LIVZON PHARMA (01513) Products Included in National Reimbursement Drug List

Stock News
·
Dec 08, 2025

Livzon Pharmaceutical Group Inc. (01513.HK, 000513.SZ) Releases November 2025 Monthly Return

Bulletin Express
·
Dec 01, 2025

LIVZON PHARMA (01513) Repurchased 16.19 Million A Shares by End-November

Stock News
·
Dec 01, 2025

Livzon Pharmaceutical Group Inc. (1513.HK) Announces Independent Director Candidate Obtains Shenzhen Stock Exchange Training Certificate

Bulletin Express
·
Nov 13, 2025

LIVZON PHARMA (01513): Independent Director Nominee Wang Zhiyao Obtains SZSE Training Certification

Stock News
·
Nov 13, 2025

Livzon Pharmaceutical Group Inc. (1513) Releases Circular and Proxy Form for 2025 First Extraordinary General Meeting

Bulletin Express
·
Nov 10, 2025

Livzon Pharmaceutical Group Inc. (1513) Announces Availability of Corporate Communications

Bulletin Express
·
Nov 10, 2025

Livzon Pharmaceutical Group Inc. Proposes Election of New Independent Non-Executive Director

Bulletin Express
·
Nov 10, 2025

LIVZON PHARMA (01513) Proposes Election of Wang Zhiyao as Independent Non-Executive Director

Stock News
·
Nov 10, 2025